Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Marseille
SEC filing record 1 source field available
Fiscal year end
31 December
Innate Pharma SA has filed 337 SEC EDGAR filings since 31 Jan 2014

SEC filing history

Showing 76-100 of 337 matching filings.

Per page
25
Current page
4
6-K File 001-39084

6-K

Filing date
25 Mar 2025
Reporting date
25 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
20 Mar 2025
Reporting date
20 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
27 Feb 2025
Reporting date
27 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
18 Feb 2025
Reporting date
17 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
27 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
21 Jan 2025
Reporting date
21 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
16 Jan 2025
Reporting date
16 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
10 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
20 Dec 2024
Reporting date
20 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
09 Dec 2024
Reporting date
09 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
06 Dec 2024
Reporting date
06 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
03 Dec 2024
Reporting date
03 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
20 Nov 2024
Reporting date
20 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
19 Nov 2024
Reporting date
19 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
13 Nov 2024
Reporting date
13 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
08 Nov 2024
Reporting date
08 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
07 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
29 Oct 2024
Reporting date
29 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
15 Oct 2024
Reporting date
14 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
30 Sep 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
23 Sep 2024
Reporting date
23 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
12 Sep 2024
Reporting date
12 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-282031

S-8

Filing date
11 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
09 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .